Professor Georgina Long hands on baton of SMR Presidency
31 October 2020
MIA’s Co-Medical Director, Professor Georgina Long AO, has passed the baton after two years as President of the Society for Melanoma Research (SMR). The US-based SMR is the world’s largest association of melanoma researchers and scientists. Professor Long was the first Australian and first female President of SMR, her election testament to her international standing as one of the world’s pre-eminent melanoma clinicians and researchers.
The annual 2020 SMR Melanoma Congress, scheduled to be held in New Orleans, was postponed due to the impact of COVID-19. Instead, a Virtual Congress was held during which Professor Long handed over the Presidency to Professor Ashani Weeraratna from Johns Hopkins School of Medicine.
In a message to SMR members, Professor Long said, ‘ The COVID-19 pandemic has presented a major challenge for all of us across the world, and we stand united in limiting the impact of the virus on our health, productivity and goals.’
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
‘Despite not being able to gather in person, as we usually do annually, we connected virtually from around the world to share our knowledge and continue our collaboration,’ Professor Long said. ‘Importantly, we highlighted the work of two fabulous researchers in the field who both received SMR Awards for their contributions – Stefani Spranger was awarded the Young Investigator Award and Yardena Samuels was awarded the Estela Medrano Award.
‘It has been an honour to lead SMR for the past two years, and I look forward to continued collaboration as we move ever closer to reaching our goal of zero deaths from melanoma,’ she said.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.